Home
Conditions
Chronic Myelomonocytic Leukemia

Clinical trial condition

Chronic Myelomonocytic Leukemia

Explore clinical trials studying Chronic Myelomonocytic Leukemia. Study availability and eligibility vary by location and protocol.

194 public trials 38 recruiting studies

Refine in advanced search Browse all conditions

Chronic Myelomonocytic Leukemia trial results

Completed

A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients

NCT02367456

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations: University of Alabama at Birmingham the Kirklin Clinic Birmingham, Alabama, United States

University of Alabama at Birmingham Birmingham, Alabama, United States

UC San Diego Moores Cancer Center La Jolla, California, United States

Smilow Cancer Center at Yale New Haven Hospital New Haven, Connecticut, United States

View all 33 locations

View Trial Details

Completed

Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML

NCT04842604

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations: Landeskrankenhaus Salzburg, Universitatsklinik fur Innere Medizin III der PMU Salzburg, Austria

Uniklinikum Salzburg, Landeskrankenhaus Salzburg Salzburg, Austria

Health Sciences Centre Winnipeg, Manitoba, Canada

CancerCare Manitoba Winnipeg, Manitoba, Canada

View all 18 locations

View Trial Details

Completed

Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation

NCT03734601

Conditions: Acute Myeloid Leukemia, B-cell Lymphoma, Bone Marrow Diseases, +33 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies

NCT01823198

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, +36 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

5-azacytidine Treatment Versus 5-azacytidine Followed by Allogeneic Stem Cell Transplantation in Elderly Patients With Myelodysplastic Syndrome (MDS)

NCT01404741

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +13 more
Locations: Charité Campus Benjamin Franklin Berlin, Germany

Uniklinikum Bonn Bonn, Germany

Universität zu Köln Cologne, Germany

Universitätsklinikum Dresden Dresden, Germany

View all 17 locations

View Trial Details

Completed

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

NCT03096782

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia, +59 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Prexasertib (LY2606368), Cytarabine, and Fludarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT02649764

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +16 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia

NCT01772420

Conditions: Adult Myelodysplastic Syndrome, Anemia, Anemia, Refractory, +16 more
Locations: University of Kansas Cancer Center Kansas City, Kansas, United States

Albert Einstein College of Medicine The Bronx, New York, United States

View Trial Details

Completed

Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease

NCT04146038

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +21 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Completed

Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT02960646

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +57 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Chronic Myelomonocytic Leukemia

Chronic Myelomonocytic Leukemia trial results

Related conditions